8.1.5. Pharmacokinetics Patients who receive the designated investigational product of interest and have at least one post-dose drug concentration measurement will be included in the PK data analysis. The actual time of sample collection will be used in PK parameter calculation. In the event that the actual sampling time is not available, the nominal time may be used if there is no evidence that the actual sampling time deviates substantially from the nominal time.